Income StatementBalance SheetCash FlowSegments
UnitedHealth Group logo

UnitedHealth Group Business Segments

Business, geographic, and product segment breakdowns

UnitedHealth Group generates $449.71B in annual revenue across 3 key segments: Optum Health (-$751.0M), Optum Insight ($2.7B), and Optum Rx ($7.1B). The company-wide operating margin is 4.19%. Based on the Q1 2026 filing.

Optum Health (TTM)-$751.0MOptum Insight (TTM)$2.7BOptum Rx (TTM)$7.1B
Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$352.79B
P/E Ratio29.29
ROE11.77%

Products & Services

Net Incurred Medical Costs

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health Insurance Product Line$264.9B———$578.7B—

Net remaining outstanding liabilities prior to 2023

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health Insurance Product Line$119.0M———$562.0M—

Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health Insurance Product Line$231.9B———$539.5B—

Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health Insurance Product Line90.0%———90.0%—

Total Medical costs payable

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health Insurance Product Line$34.2B———$39.3B—

Revenue from Products and Services

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Services$9.3B$9.0B$9.0B$9.8B$10.3B$9.8B

Accounts Receivable, after Allowance for Credit Loss, Current

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
unh:ProductsandservicesMember$9.9B$11.7B$9.8B$10.1B$9.7B$9.3B

Business Segments

D&A

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight$336.0M$376.0M$351.0M$359.0M$368.0M$392.0M
Optum Health$291.0M$255.0M$296.0M$309.0M$319.0M$246.0M
UnitedHealthcare$216.0M$219.0M$221.0M$221.0M$222.0M$218.0M
Optum Rx$198.0M$211.0M$216.0M$210.0M$208.0M$173.0M

Earnings from operations

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$3.0B$5.2B$2.1B$1.8B$319.0M$5.7B
Optum Rx$1.7B$1.3B$1.4B$1.5B$2.9B$1.2B
Optum Health$1.8B$1.4B$636.0M$255.0M-$2.8B$1.1B
Optum Insight$1.3B$1.2B$998.0M$706.0M$0.0$963.0M

Dispositions, foreign currency effects and adjustments, net

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight-$81.8M-$61.8M-$61.8M-$61.8M-$61.8M—
Optum Rx-$1.5M-$61.5M-$61.5M-$61.5M-$61.5M—
UnitedHealthcare-$179.3M$8.8M$8.8M$8.8M$8.8M—

Earnings before income taxes

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Rx$1.7B$1.3B$1.4B$1.5B$2.9B$1.2B
Optum Health$1.8B$1.4B$636.0M$255.0M-$2.8B$1.1B
Optum Insight$1.3B$1.2B$998.0M$706.0M$0.0$963.0M

Gain (Loss) on Portfolio Actions

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight—$17.0M$17.0M$17.0M$17.0M—
Optum Rx—-$375.0M-$375.0M-$375.0M-$375.0M—

Goodwill

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight$19.0B———$18.7B—
Optum Rx$21.8B———$21.8B—
UnitedHealthcare$27.2B———$27.2B—

Incremental loss on disposition of business

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Health—————$314.0M

Interest Expense

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Health$0.0$0.0$0.0$0.0$0.0$0.0
Optum Insight$0.0$0.0$0.0$0.0$0.0$0.0
Optum Rx$0.0$0.0$0.0$0.0$0.0$0.0

Investment & Other Income

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$543.0M$528.0M$573.0M$568.0M$504.0M$504.0M
Optum Insight$77.0M$233.0M$32.0M$41.0M$4.0M$342.0M
Optum Health$853.0M$225.0M$455.0M$472.0M$111.0M$244.0M
Optum Rx$78.0M$47.0M$48.0M$51.0M$28.0M$41.0M

Loss On Portfolio Actions

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Health—————$306.0M

Loss on sale of subsidiary and subsidiaries held for sale

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$0.0-$15.0M-$41.0M-$83.0M-$126.0M-$72.0M
Optum Health$0.0$0.0$0.0$0.0$0.0$0.0
Optum Insight$0.0$0.0$0.0$0.0$0.0$0.0
Optum Rx$0.0$0.0$0.0$0.0$0.0$0.0

Premiums

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$71.1B$81.5B$83.0B$83.9B$83.9B$83.0B
Optum Health$5.3B$5.0B$4.9B$5.1B$4.9B$4.6B
Optum Insight$0.0$0.0$0.0$0.0$0.0$0.0
Optum Rx$0.0$0.0$0.0$0.0$0.0$0.0

Restructuring Costs

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight—$59.0M$59.0M$59.0M$59.0M$339.0M
Optum Health—$425.0M$425.0M$425.0M$425.0M$135.0M
Optum Rx—$97.3M$97.3M$97.3M$97.3M—
UnitedHealthcare—$38.3M$38.3M$38.3M$38.3M—

Segment, Expenditure, Addition to Long-Lived Assets

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight$304.0M$353.0M$289.0M$267.0M$275.0M$306.0M
UnitedHealthcare$200.0M$196.0M$193.0M$238.0M$190.0M$204.0M
Optum Health$284.0M$264.0M$306.0M$282.0M$370.0M$184.0M
Optum Rx$124.0M$85.0M$98.0M$103.0M$113.0M$69.0M

Total Assets

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$119.0B$131.9B$129.6B$130.5B$124.1B$129.0B
Optum Health$96.5B$72.0B$96.5B$100.9B$101.0B$73.6B
Optum Insight$34.5B$60.2B$33.7B$33.8B$35.4B$63.1B
Optum Rx$59.1B$60.4B$61.7B$62.5B$62.3B$58.5B

Total operating costs

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$71.2B$79.4B$84.0B$85.3B$86.8B$80.6B
Optum Rx$34.0B$33.8B$37.0B$38.1B$38.6B$34.5B
Optum Health$23.9B$23.4B$24.6B$25.6B$28.3B$23.0B
Optum Insight$3.5B$3.9B$3.8B$4.2B$5.1B$4.2B

Total revenues

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$74.1B$84.6B$86.1B$87.1B$87.1B$86.3B
Optum Rx$35.8B$35.1B$38.5B$39.7B$41.5B$35.7B
Optum Health$25.7B$24.8B$25.2B$25.9B$25.5B$24.1B
Optum Insight$4.8B$5.0B$4.8B$4.9B$5.0B$5.1B

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$3.0B$5.2B$2.0B$1.7B$193.0M$5.6B

Acquisitions

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight$0.0$0.0$0.0$0.0$0.0—
UnitedHealthcare$0.0$0.0$0.0$0.0$0.0—

Gain on disposition of business

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight—————$525.0M

Gain On Portfolio Actions

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Optum Insight—————$528.0M
Optum Rx—————$8.0M

Interest Expense, Operating and Nonoperating

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
UnitedHealthcare$0.0$0.0$0.0$0.0$0.0$0.0